Catalyst Wire Dossier Catalyst Wire Dossier

RSV maternal unadjuvanted vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RSV maternal unadjuvanted vaccine, covering 2021-12-13 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers [Phase 3]

See pricing